DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 02 · Volume 57 · 1987 DOI: 10.1055/s-008-39933

Original Article

131
Bröcker-Vriends, A H J T; Briët, E; Quadt, R; Dreesen, J C F M; Bakker, E; Claassen-Tegelaar, R; Kanhai, H H H; van de Kamp, J J P; Pearson, P L: Genotype Assignment of Haemophilia A by Use of Intragenic and Extragenic Restriction Fragment Length Polymorphisms
140
de Jong, Egbert; Knot, Eduard A R; Piket, Dick; Iburg, Alfred H C; Rijken, Dick C; Veenhof, Kees H N; Dooijewaard, Gerard; ten Cate, Jan W: Increased Plasminogen Activator Inhibition Levels in Malignancy
144
Rosner, Esther; Pauzner, Rachel; Lusky, Ayala; Modan, Michaela; Many, Amira: Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity
154
de Moerloose, P A; Reber, G; Vernet, Ph; Minazio, Ph; Bouvier, C A: Antithrombin III Geneva: A Hereditary Abnormal AT III with Defective Heparin Cofactor Activity
158
Ushikubi, Fumitaka; Okuma, Minoru; Kanaji, Kenji; Sugiyama, Tateo; Ogorochi, Toshiya; Narumiya, Shuh; Uchino, Haruto: Hemorrhagic Thrombocytopathy with Platelet Thromboxane A2 Receptor Abnormality: Defective Signal Transduction with Normal Binding Activity
171
Jansen, J W C M; Haverkate, F; Koopman, J; Nieuwenhuis, H K; Kluft, C; Boschman, Th A C: Influence of Factor Xllla Activity on Human Whole Blood Clot Lysis In Vitro
183
Sala, N; Borrell, M; Bauer, K A; Viganò-D’Angelo, S; Fontcuberta, J; Félez, J; Rutllant, M L: Dysfunctional Activated Protein C (PC Cádiz) in a Patient with Thrombotic Disease
187
Handley, Dean A; Van Valen, Ronald G; Winslow, Christine M; Tomesch, John C; Saunders, Robert N: In Vitro and In Vivo Pharmacological Profiles of the PAF Receptor Antagonist SRI 63-675
196
Bertina, R M; van der Linden, I K; Engesser, L; Muller, H P; Brommer, E J P: Hereditary Heparin Cofactor II Deficiency and the Risk of Development of Thrombosis
217
226
van den Besselaar, A M H P; Meeuwisse-Braun, J; Jansen-Grüter, R; Bertina, R M: Monitoring Heparin Therapy by the Activated Partial Thromboplastin Time - The Effect of Pre-Analytical Conditions

Letters to the Editor

234
Forestier, François; Daffos, Fernand; Rainaut, Martine; Toulemonde, Francis: Low Molecular Weight Heparin (CY 216) Does Not Cross the Placenta During the Third Trimester of Pregnancy
235
Gresele, Paolo; Amout, Jef; Vermylen, Jos: Dipyridamole Inhibits Leukotriene B4 Synthesis
238
Finazzi, Guido; Cortelazzo, Sergio; Viero, Piera; Galli, Monica; Barbui, Tiziano: Maternal Lupus Anticoagulant and Fatal Neonatal Thrombosis
239
de Prost, D; Katlama, C; Pialoux, G; Karsenty-Mathonnet, F; Wolff, M: Heparin-Like Anticoagulant Associated with AIDS